Cargando…
A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India
PURPOSE: To derive consensus statements for surgical management of proliferative diabetic retinopathy (PDR) for vitreoretinal (VR) surgeons. METHODS: Thirteen prolific VR surgeons representing all regions of India were invited to participate in a 42-point questionnaire based on the Delphi methodolog...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725119/ https://www.ncbi.nlm.nih.gov/pubmed/34708794 http://dx.doi.org/10.4103/ijo.IJO_1265_21 |
_version_ | 1784626049517092864 |
---|---|
author | Sengupta, Sabyasachi Sindal, Manavi D Shanmugam, P Mahesh Bhende, Pramod Ratra, Dhanashree Nagpal, Manish Narayanan, Raja Rajendran, Anand Saravanan, Veerappan Kelkar, Aditya Maiti, Aniruddha Chakraborty, Debdulal Dogra, Mohit Behera, Sourabh |
author_facet | Sengupta, Sabyasachi Sindal, Manavi D Shanmugam, P Mahesh Bhende, Pramod Ratra, Dhanashree Nagpal, Manish Narayanan, Raja Rajendran, Anand Saravanan, Veerappan Kelkar, Aditya Maiti, Aniruddha Chakraborty, Debdulal Dogra, Mohit Behera, Sourabh |
author_sort | Sengupta, Sabyasachi |
collection | PubMed |
description | PURPOSE: To derive consensus statements for surgical management of proliferative diabetic retinopathy (PDR) for vitreoretinal (VR) surgeons. METHODS: Thirteen prolific VR surgeons representing all regions of India were invited to participate in a 42-point questionnaire based on the Delphi methodology describing various surgical scenarios commonly encountered in PDR. Consensus was derived using predefined robust analytics. Scenarios that returned a moderate consensus in round 1 were taken to round 2 as per the Delphi methodology. After considering all inputs, the final consensus criteria were developed. RESULTS: A strong consensus was derived about waiting for 4 weeks before considering vitrectomy. In treatment-naïve eyes with fresh vitreous hemorrhage (VH), the wait time was slightly shorter for extramacular tractional retinal detachment (2–4 weeks) and longer (4–6 weeks) for eyes treated previously with laser or anti-VEGF agents. The expert panel recommended using preoperative anti-VEGF only in eyes with large membranes requiring extensive dissection. For post vitrectomy VH, while a conservative approach was recommended for the first episode of VH, experts recommended immediate vitreous lavage for recurrent episodes of VH. In eyes with iris neovascularization, the panel recommended immediate anti-VEGF injection followed by early vitreous lavage in nonresponsive eyes. A strong consensus was derived for stopping antiplatelet agents before surgery, while there was only a moderate consensus for performing vitrectomy for recalcitrant macular edema unresponsive to anti-VEGF injections in the absence of traction. CONCLUSION: This study provides valuable consensus on managing the different scenarios encountered during surgical management of PDR and should help guide the VR surgeons in clinical decision-making. |
format | Online Article Text |
id | pubmed-8725119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-87251192022-01-20 A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India Sengupta, Sabyasachi Sindal, Manavi D Shanmugam, P Mahesh Bhende, Pramod Ratra, Dhanashree Nagpal, Manish Narayanan, Raja Rajendran, Anand Saravanan, Veerappan Kelkar, Aditya Maiti, Aniruddha Chakraborty, Debdulal Dogra, Mohit Behera, Sourabh Indian J Ophthalmol Original Article PURPOSE: To derive consensus statements for surgical management of proliferative diabetic retinopathy (PDR) for vitreoretinal (VR) surgeons. METHODS: Thirteen prolific VR surgeons representing all regions of India were invited to participate in a 42-point questionnaire based on the Delphi methodology describing various surgical scenarios commonly encountered in PDR. Consensus was derived using predefined robust analytics. Scenarios that returned a moderate consensus in round 1 were taken to round 2 as per the Delphi methodology. After considering all inputs, the final consensus criteria were developed. RESULTS: A strong consensus was derived about waiting for 4 weeks before considering vitrectomy. In treatment-naïve eyes with fresh vitreous hemorrhage (VH), the wait time was slightly shorter for extramacular tractional retinal detachment (2–4 weeks) and longer (4–6 weeks) for eyes treated previously with laser or anti-VEGF agents. The expert panel recommended using preoperative anti-VEGF only in eyes with large membranes requiring extensive dissection. For post vitrectomy VH, while a conservative approach was recommended for the first episode of VH, experts recommended immediate vitreous lavage for recurrent episodes of VH. In eyes with iris neovascularization, the panel recommended immediate anti-VEGF injection followed by early vitreous lavage in nonresponsive eyes. A strong consensus was derived for stopping antiplatelet agents before surgery, while there was only a moderate consensus for performing vitrectomy for recalcitrant macular edema unresponsive to anti-VEGF injections in the absence of traction. CONCLUSION: This study provides valuable consensus on managing the different scenarios encountered during surgical management of PDR and should help guide the VR surgeons in clinical decision-making. Wolters Kluwer - Medknow 2021-11 2021-10-29 /pmc/articles/PMC8725119/ /pubmed/34708794 http://dx.doi.org/10.4103/ijo.IJO_1265_21 Text en Copyright: © 2021 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Sengupta, Sabyasachi Sindal, Manavi D Shanmugam, P Mahesh Bhende, Pramod Ratra, Dhanashree Nagpal, Manish Narayanan, Raja Rajendran, Anand Saravanan, Veerappan Kelkar, Aditya Maiti, Aniruddha Chakraborty, Debdulal Dogra, Mohit Behera, Sourabh A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India |
title | A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India |
title_full | A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India |
title_fullStr | A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India |
title_full_unstemmed | A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India |
title_short | A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India |
title_sort | delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725119/ https://www.ncbi.nlm.nih.gov/pubmed/34708794 http://dx.doi.org/10.4103/ijo.IJO_1265_21 |
work_keys_str_mv | AT senguptasabyasachi adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT sindalmanavid adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT shanmugampmahesh adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT bhendepramod adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT ratradhanashree adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT nagpalmanish adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT narayananraja adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT rajendrananand adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT saravananveerappan adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT kelkaraditya adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT maitianiruddha adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT chakrabortydebdulal adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT dogramohit adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT beherasourabh adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT senguptasabyasachi delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT sindalmanavid delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT shanmugampmahesh delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT bhendepramod delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT ratradhanashree delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT nagpalmanish delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT narayananraja delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT rajendrananand delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT saravananveerappan delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT kelkaraditya delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT maitianiruddha delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT chakrabortydebdulal delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT dogramohit delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia AT beherasourabh delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia |